Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 359

1.

Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains.

Perrot S, Schaefer C, Knight T, Hufstader M, Chandran AB, Zlateva G.

BMC Musculoskelet Disord. 2012 Feb 17;13:22. doi: 10.1186/1471-2474-13-22.

2.

Characteristics of patients with fibromyalgia in France and Germany.

Perrot S, Winkelmann A, Dukes E, Xu X, Schaefer C, Ryan K, Chandran A, Sadosky A, Zlateva G.

Int J Clin Pract. 2010 Jul;64(8):1100-8. doi: 10.1111/j.1742-1241.2010.02418.x. Epub 2010 May 20.

PMID:
20497264
3.

The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States.

Schaefer C, Chandran A, Hufstader M, Baik R, McNett M, Goldenberg D, Gerwin R, Zlateva G.

Health Qual Life Outcomes. 2011 Aug 22;9:71. doi: 10.1186/1477-7525-9-71.

4.
5.

Toward characterization and definition of fibromyalgia severity.

Silverman S, Sadosky A, Evans C, Yeh Y, Alvir JM, Zlateva G.

BMC Musculoskelet Disord. 2010 Apr 8;11:66. doi: 10.1186/1471-2474-11-66.

6.

Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study.

Winkelmann A, Perrot S, Schaefer C, Ryan K, Chandran A, Sadosky A, Zlateva G.

Appl Health Econ Health Policy. 2011 Mar 1;9(2):125-36. doi: 10.2165/11535250-000000000-00000.

PMID:
21332254
7.

The burden of neuropathic pain: results from a cross-sectional survey.

McDermott AM, Toelle TR, Rowbotham DJ, Schaefer CP, Dukes EM.

Eur J Pain. 2006 Feb;10(2):127-35.

PMID:
16310716
8.

Do we need core sets of fibromyalgia domains? The assessment of fibromyalgia (and other rheumatic disorders) in clinical practice.

Wolfe F, Hassett AL, Katz RS, Michaud K, Walitt B.

J Rheumatol. 2011 Jun;38(6):1104-12. doi: 10.3899/jrheum.100511. Epub 2011 Feb 1.

PMID:
21285168
9.

Autonomic dysfunction in fibromyalgia assessed by the Composite Autonomic Symptoms Scale (COMPASS).

Solano C, Martinez A, Becerril L, Vargas A, Figueroa J, Navarro C, Ramos-Remus C, Martinez-Lavin M.

J Clin Rheumatol. 2009 Jun;15(4):172-6. doi: 10.1097/RHU.0b013e3181a1083d.

PMID:
19342959
10.

Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.

Bennett R, Russell IJ, Choy E, Spaeth M, Mease P, Kajdasz D, Walker D, Wang F, Chappell A.

Clin Ther. 2012 Apr;34(4):824-37. doi: 10.1016/j.clinthera.2012.02.013. Epub 2012 Mar 14.

PMID:
22421576
11.

Estimating the economic benefits of positive shifts in fibromyalgia severity: an exploratory analysis based on modeling of clinical trial data of pregabalin.

Cappelleri JC, Bushmakin AG, Zlateva G, Chandran A.

J Med Econ. 2013;16(1):55-61. doi: 10.3111/13696998.2012.727930. Epub 2012 Sep 17.

PMID:
22954060
12.

The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort.

Fitzcharles MA, Ste-Marie PA, Panopalis P, Ménard H, Shir Y, Wolfe F.

BMC Musculoskelet Disord. 2012 Sep 20;13:179. doi: 10.1186/1471-2474-13-179.

13.

Minimal clinically important difference in the fibromyalgia impact questionnaire.

Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB.

J Rheumatol. 2009 Jun;36(6):1304-11. doi: 10.3899/jrheum.081090. Epub 2009 Apr 15.

PMID:
19369473
15.

Effect of fibromyalgia syndrome on the health-related quality of life and economic burden in Korea.

Kim SK, Kim SH, Lee CK, Lee HS, Lee SH, Park YB, Park HJ, Son MJ, Lee SS.

Rheumatology (Oxford). 2013 Feb;52(2):311-20. doi: 10.1093/rheumatology/kes255. Epub 2012 Sep 28.

PMID:
23024016
16.

Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.

Zhu TY, Tam LS, Li EK.

Rheumatology (Oxford). 2011 Jul;50(7):1293-301. doi: 10.1093/rheumatology/ker014. Epub 2011 Feb 17.

PMID:
21330341
17.

Burden of illness in fibromyalgia patients with comorbid depression.

Bateman L, Sarzi-Puttini P, Burbridge CL, Landen JW, Masters ET, Bhadra Brown P, Scavone JM, Emir B, Vissing RS, Clair AG, Pauer LR.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S106-13. Epub 2016 Mar 10.

PMID:
27057659
18.

Specialized rheumatology nurse substitutes for rheumatologists in the diagnostic process of fibromyalgia: a cost-consequence analysis and a randomized controlled trial.

Kroese ME, Severens JL, Schulpen GJ, Bessems MC, Nijhuis FJ, Landewé RB.

J Rheumatol. 2011 Jul;38(7):1413-22. doi: 10.3899/jrheum.100753. Epub 2011 Apr 1.

PMID:
21459951
19.

Cross-cultural adaptation and validation of a Bengali version of the modified fibromyalgia impact questionnaire.

Muquith MA, Islam MN, Haq SA, Ten Klooster PM, Rasker JJ, Yunus MB.

BMC Musculoskelet Disord. 2012 Aug 27;13:157. doi: 10.1186/1471-2474-13-157.

20.

The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire.

Wolfe F, Hawley DJ, Goldenberg DL, Russell IJ, Buskila D, Neumann L.

J Rheumatol. 2000 Aug;27(8):1989-99.

PMID:
10955343

Supplemental Content

Support Center